RNXT – renovorx, inc. (US:NASDAQ)
Stock Stats
News
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
RenovoRx (NASDAQ:RNXT) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
Form 8-K RenovoRx, Inc. For: Feb 06
Form SCHEDULE 13G/A RenovoRx, Inc. Filed by: HIRSCHMAN ORIN
Form 4 RenovoRx, Inc. For: Jan 21 Filed by: Agah Ramtin
Form 4 RenovoRx, Inc. For: Dec 31 Filed by: Agah Ramtin
Form 4 RenovoRx, Inc. For: Dec 30 Filed by: Agah Ramtin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.